Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)

Clinical trial NCT01236638 · COMPLETED

Trial details

NCT number: NCT01236638
Sponsor: Sierra Oncology LLC - a GSK company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-Polycythemia Vera Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis

Start date: 2010-11-01
Primary completion: 2014-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.